XML 53 R31.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock Based Compensation | 12 Months Ended
--- | ---
Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock Based Compensation | During the year ended March 31, 2020, no stock options were granted. Total compensation expense related to options granted was $216 for the year ended March 31, 2020 and $215 for the year ended March 31, 2019. As of March 31, 2020, there was total remaining compensation expense of $112 related to stock options, which will be recorded over a weighted average period of approximately 0.52 years. During the year ended March 31, 2020, options to purchase a total of 230,000 shares were exercised. As disclosed in Note 24, on October 6, 2017, the Company issued restricted stock awards totaling 3,900,000 shares of its common stock to 16 employees and awarded nonqualified stock options to purchase an aggregate of 360,000 shares of its common stock at a strike price of $1.98 per share to two employees. Shares of restricted stock have the same dividend and voting rights as common stock while options do not. All awards were issued at the fair value of the underlying shares at the grant date. The Company has determined fair value of stock options using the Black-Scholes option valuation model based on the following key assumptions:
Term (years) |  |  | 3 |
Volatility |  |  | 165.33 | %
Risk-free rate |  |  | 1.66 | %
Stock-based compensation expense for the cost of the awards granted is based on the grant-date fair value. For stock option awards, the fair value is estimated at the date of grant using the Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, changes to which can materially affect the fair value estimate. Additionally, there may be other factors that would otherwise have a significant effect on the value of employee stock options granted but are not considered by the model. Accordingly, while management believes that the Black-Scholes option-pricing model provides a reasonable estimate of fair value, the model does not necessarily provide the best single measure of fair value for the Company's employee stock options. The following is a summary of stock option activity for year ended March 31, 2020:
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (In Years) |  |  | Aggregate Intrinsic Value |
Outstanding, March 31, 2019 |  |  | 350,000 |  |  | $ | 1.98 |  |  |  | 8.52 |  |  | $ | 2,342 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (230,000 | ) |  |  | 1.98 |  |  |  | - |  |  |  | 2,630 |
Forfeited/cancelled/expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding, at March 31, 2020 |  |  | 120,000 |  |  | $ | 1.98 |  |  |  | 7.52 |  |  |  | 1,466 |
Exercisable, at March 31, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
During the year ended March 31, 2020, no restricted shares were awarded. The compensation expense related to restricted stock awards was $2,409 during the year ended March 31, 2020, and $3,283 during the year ended March 31, 2019. As of March 31, 2020, there was $977 of total unrecognized compensation cost related to non-vested shares of restricted stock granted. The cost is expected to be recognized over a weighted average period of 0.52 years. The table below summarizes the activity for the Company's restricted stock outstanding during the year ended March 31, 2020:
|  | Shares |  |  | Weighted Average Fair Value |
Outstanding, March 31, 2019 |  |  | 2,275,000 |  |  | $ | 4,777 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | - |  |  |  | - |
Forfeited/cancelled/expired |  |  | - |  |  |  | - |
Outstanding, at March 31, 2020 |  |  | 2,275,000 |  |  | $ | 4,777 |
During the year ended March 31, 2020, the Company recorded expenses for share based payments in the amount of $1,052.

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration